Zhengrong Li - Concepedia

Author

Zhengrong Li

Nanchang University ORCID

Also Known As

Li Zhengrong, Li, Zhengrong, ZHENGRONG LI, Zheng-Rong Li, Zheng-rong LI, Zheng-rong Li, ZhengRong Li, Zhengrong Li

165

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Nanchang University First Affiliated Hospital of Nanchang University Nanjing Medical University First Affiliated Hospital of Jiangxi Medical College Shanghai Jiao Tong University

About

Zhengrong Li is an author at Nanchang University specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.4K
2	Engineering	7	7	179
3	Natural Sciences	3	3	105
4	Health Sciences	1	1	42
5	Social Sciences	1	1	37

Zhengrong Li

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion David M. Brown, Peter A. Campochiaro, Rishi P. Singh, Ophthalmology Ocular DiseaseMacular EdemaOphthalmology	2010	1.1K
Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration Allen C. Ho, Brandon Busbee, Carl D. Regillo, Ophthalmology	2014	577
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration Brandon Busbee, Allen C. Ho, David M. Brown, Ophthalmology	2013	492
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions Jeffrey S. Heier, Peter A. Campochiaro, Linda Yau, Ophthalmology Diabetic RetinopathyOcular DiseaseRetinal Vein OcclusionsOphthalmologyMedicine	2012	462
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH) Solange Peters, Scott Gettinger, Melissa L. Johnson, Journal of Clinical Oncology	2017	415
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration Brian L. Yaspan, David F. Williams, Frank G. Holz, Science Translational Medicine Complement SystemOcular DiseaseOphthalmologyFactor DAge-related Diseases	2017	178
miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3 Zhengrong Li, Yi Cao, Zhigang Jie, Cancer Letters Mir-551a InhibitTumor BiologyMedicineCancer BiologyMicrorna Detection	2012	104
Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis Zhengrong Li, Wenhua Zhan, Zhao Wang, Biochemical and Biophysical Research Communications Tumor BiologyReduces Peritoneal MetastasisMedicinePrl-3 Gene ExpressionCancer Genomics	2006	99
Investigation of archaeosomes as carriers for oral delivery of peptides Zhengrong Li, Jian Chen, Wenqiang Sun, Biochemical and Biophysical Research Communications MedicinePeptide EngineeringPeptide LibraryOral DeliveryPeptide Synthesis	2010	82
Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors Hong Jiang, Dongming Geng, Hongqia Liu, Drug Delivery	2016	81

Page 1